Growth & profitability
- Revenue has grown 111.3% per year over the past 1 years.
- Operating margin has expanded, at -32.4% in the latest year.
XLAB Financials Exascale Labs Holdings Inc.
2 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
ROEROA
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2026 | $15M | -$12M | 16.3% | -32.4% | 48.3% | -180.8% | — | — | $3M |
| 2025 | $7M | -$8M | 15.8% | -43.4% | 58.9% | -104.6% | -$1M | — | $4M |
Valuation over time
How the market has priced XLAB against its own fundamentals since 2026-08 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-sales ratio has fallen from 0.0× (Aug '26) to 0.0× (Nov '26).
P/S
Frequently asked questions
Is XLAB growing its revenue and profit?
Over the past 1 years, Exascale Labs Holdings Inc.'s revenue has grown 111.3% per year. These are computed facts, not advice.
How much debt does XLAB have?
As of FY2026, Exascale Labs Holdings Inc. reported — of total debt against $3M of cash.
What is XLAB's profit margin?
In FY2026, gross margin was 16.3%, operating margin -32.4%, and net margin -82.1%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.